Home Healthcare IT Cancer Treatment Market Size, Analysis, Growth Report, Share, forecast period 2026

Cancer Treatment Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Others), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By End-users (Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2018-2026

Report Code: SRHI26DR
Last Updated : Jan 02, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Cancer Treatment Market Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. U.S.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Canada
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. U.K.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. China
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. UAE
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Blood Cancer
        1. By Value
      3. Lung Cancer
        1. By Value
      4. Colorectal Cancer
        1. By Value
      5. Prostate Cancer
        1. By Value
      6. Breast Cancer
        1. By Value
      7. Cervical Cancer
        1. By Value
      8. Others
        1. By Value
    3. By Therapy
      1. Introduction
        1. Therapy By Value
      2. Chemotherapy
        1. By Value
      3. Targeted Therapy
        1. By Value
      4. Immunotherapy
        1. By Value
      5. Hormonal Therapy
        1. By Value
      6. Others
        1. By Value
    4. By End-users
      1. Introduction
        1. End-users By Value
      2. Hospitals
        1. By Value
      3. Specialty Clinics
        1. By Value
      4. Cancer & Radiation Therapy Centers
        1. By Value
    5. Brazil
      1. By Application
        1. Introduction
          1. Application By Value
        2. Blood Cancer
          1. By Value
        3. Lung Cancer
          1. By Value
        4. Colorectal Cancer
          1. By Value
        5. Prostate Cancer
          1. By Value
        6. Breast Cancer
          1. By Value
        7. Cervical Cancer
          1. By Value
        8. Others
          1. By Value
      2. By Therapy
        1. Introduction
          1. Therapy By Value
        2. Chemotherapy
          1. By Value
        3. Targeted Therapy
          1. By Value
        4. Immunotherapy
          1. By Value
        5. Hormonal Therapy
          1. By Value
        6. Others
          1. By Value
      3. By End-users
        1. Introduction
          1. End-users By Value
        2. Hospitals
          1. By Value
        3. Specialty Clinics
          1. By Value
        4. Cancer & Radiation Therapy Centers
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Cancer Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. F. Hoffmann-La Roche AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bristol-Myers Squibb Company
    3. AbbVie INC.
    4. Johnson & Johnson
    5. Celgene Corporation
    6. Astellas Pharma INC.
    7. Pfizer INC.
    8. Novartis AG
    9. Merck KGaA
    10. Eli Lilly
    11. AstraZeneca plc
    12. Bayer AG
    13. Takeda Pharmaceutical Company Limited.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Global Anthrax Treatment market size was valued at USD 332.06 million in 2022. It is projected to reach USD 636.65 million by 2031, growing at a CAGR of 7.5% during the forecast period (2023-2031). Anthrax Therapeutics
Buy Now
Global Report
Anti-Acne Treatment Market Size and Trends The global anti-acne treatment market size was valued at USD 10.08 billion in 2023. It is projected to reach from USD 10.53 billion in 2024 to USD 15.05 billion by 2032, growing at a CAGR of 4.56% during th
Buy Now
Global Report
Cancer Stem Cell Market Size & Trends The global cancer stem cell market size was valued at USD 2.73 billion in 2024 and is projected to reach from USD 2.99 billion in 2025 to USD 6.08 billion by 2033, exhibiting a CAGR
Buy Now
Global Report
The global cervical cancer treatment market size was valued at 7.71 USD billion in 2022. It is projected to reach USD 11.76 billion by 2031, growing at a CAGR of 4.8% during the forecast period (2023–2031). The body's unchecked cell proli
Buy Now
Global Report
The global seed treatment market size was valued at USD 8822.18 million in 2022. It is projected to reach USD 26041.42 million by 2031, growing at a CAGR of 12.78% during the forecast period (2023–2031). Seed treatment safeguards plants f
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :